Fig. 6
From: Immune-Related Long Non-coding RNA Constructs a Prognostic Signature of Ovarian Cancer
Tumor immunotherapy assessment by risk assessment signature. Risk signature was related to tumor-infiltrating immune cells (A). The box-plot showed that the low-risk group was positively correlated with specific immune cells, such as B cells and T cells (B-D), while was negatively correlated with non-specific immune cells, such as neutrophils, macrophages and mast cells (E-G)